These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33836095)

  • 1. Pathologic upstaging in resected pancreatic adenocarcinoma: Risk factors and impact on survival.
    Olecki EJ; Stahl KA; Torres MB; Peng JS; Shen C; Dixon MEB; Gusani NJ
    J Surg Oncol; 2021 Jul; 124(1):79-87. PubMed ID: 33836095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of time-to-surgery with outcomes in clinical stage I-II pancreatic adenocarcinoma treated with upfront surgery.
    Swords DS; Zhang C; Presson AP; Firpo MA; Mulvihill SJ; Scaife CL
    Surgery; 2018 Apr; 163(4):753-760. PubMed ID: 29248179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors.
    Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S
    J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prediction of prognosis of patients with pancreatic adenocarcinoma with curative intent resection by means of histologic grade and pathologic N stage].
    Soriano-Izquierdo A; Adet AC; Gallego R; Miquel R; Castells A; Pellisé M; Nadal C; López-Boado MA; Piqué JM; Gascón P; Conill C; Bombí A; Fernández-Cruz L; Maurel J; Navarro S
    Med Clin (Barc); 2009 Feb; 132(5):163-71. PubMed ID: 19211081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
    Kantor O; Talamonti MS; Lutfi W; Wang CH; Winchester DJ; Marsh R; Prinz RA; Baker MS
    Surgery; 2016 Dec; 160(6):1466-1476. PubMed ID: 27614417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripancreatic soft tissue involvement: independent outcome predictor in patients with resected pancreatic adenocarcinoma.
    Hamidian Jahromi A; Zibari GB; Jafarimehr E; Chu Q; Wellman GP; Shi R; Johnson LW; Shokouh-Amiri H
    Int Surg; 2014; 99(1):62-70. PubMed ID: 24444272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
    J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base.
    Johnston WC; Hoen HM; Cassera MA; Newell PH; Hammill CW; Hansen PD; Wolf RF
    HPB (Oxford); 2016 Jan; 18(1):21-8. PubMed ID: 26776847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of facility type on survival outcomes after pancreatectomy for pancreatic adenocarcinoma.
    Chu QD; Zhou M; Peddi P; Medeiros KL; Zibari GB; Shokouh-Amiri H; Wu XC
    HPB (Oxford); 2017 Dec; 19(12):1046-1057. PubMed ID: 28967535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive risk factors for peritoneal recurrence after pancreatic cancer resection and strategies for its prevention.
    Ariake K; Motoi F; Ohtsuka H; Fukase K; Masuda K; Mizuma M; Hayashi H; Nakagawa K; Morikawa T; Maeda S; Takadate T; Naitoh T; Egawa S; Unno M
    Surg Today; 2017 Dec; 47(12):1434-1442. PubMed ID: 28434080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underuse of surgical resection among elderly patients with early-stage pancreatic cancer.
    He W; Zhao H; Chan W; Lopez D; Shroff RT; Giordano SH
    Surgery; 2015 Nov; 158(5):1226-34. PubMed ID: 26138347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undertreatment of Pancreatic Cancer: Role of Surgical Pathology.
    Olecki EJ; Stahl K; Peng JS; Dixon M; Gusani NJ; Shen C
    Ann Surg Oncol; 2021 Mar; 28(3):1581-1592. PubMed ID: 32851518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic disparities in surgical treatment recommendation patterns and survival for pancreatic adenocarcinoma.
    Salami A; Alvarez NH; Joshi ART
    HPB (Oxford); 2017 Nov; 19(11):1008-1015. PubMed ID: 28838634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?
    Bott MJ; Patel AP; Crabtree TD; Colditz GA; Kreisel D; Krupnick AS; Patterson GA; Broderick S; Meyers BF; Puri V
    Ann Thorac Surg; 2015 Dec; 100(6):2048-53. PubMed ID: 26277562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
    Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
    Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the U.S. National Cancer Database.
    Passeri MJ; Baker EH; Siddiqui IA; Templin MA; Martinie JB; Vrochides D; Iannitti DA
    Curr Oncol; 2019 Jun; 26(3):e346-e356. PubMed ID: 31285679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality.
    Xiao R; Ward MC; Yang K; Adelstein DJ; Koyfman SA; Prendes BL; Burkey BB
    Cancer; 2018 Apr; 124(7):1400-1414. PubMed ID: 29315499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to the initiation of adjuvant chemotherapy does not impact survival in patients with resected pancreatic cancer.
    Mirkin KA; Greenleaf EK; Hollenbeak CS; Wong J
    Cancer; 2016 Oct; 122(19):2979-87. PubMed ID: 27328270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.
    Shubert CR; Bergquist JR; Groeschl RT; Habermann EB; Wilson PM; Truty MJ; Smoot RL; Kendrick ML; Nagorney DM; Farnell MB
    Surgery; 2016 Oct; 160(4):1080-1096. PubMed ID: 27522556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic factors associated with early mortality after surgical resection for pancreatic cancer--under-analysis of cumulative survival curve.
    Takamori H; Hiraoka T; Kanemitsu K; Tsuji T; Hamada C; Baba H
    World J Surg; 2006 Feb; 30(2):213-8. PubMed ID: 16425074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.